No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical Trials

No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical Trials

Kamal Hamed, Tatiana Wiktorowicz, Maziar Assadi Gehr Basilea Pharmaceutica International Ltd., Basel, SwitzerlandCorrespondence: Kamal HamedBasilea Pharmaceutica International Ltd., Grenzacherstrasse 487, Basel 4005, SwitzerlandTel +41 61 567 1588Fax +41 61 606 1216Email kamal.hamed@basilea.comPurpo...

Full description

Bibliographic Details
Main Authors: Hamed K, Wiktorowicz T, Assadi Gehr M
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:Infection and Drug Resistance
Subjects:
diiha
direct antiglobulin test
hemolysis
pneumonia
absssis
staphylococcus aureus bacteremia
Online Access:https://www.dovepress.com/no-evidence-for-ceftobiprole-induced-immune-hemolytic-anemia-in-three--peer-reviewed-article-IDR

Internet

https://www.dovepress.com/no-evidence-for-ceftobiprole-induced-immune-hemolytic-anemia-in-three--peer-reviewed-article-IDR

Similar Items